14 insiders reported 317 Form 4 transactions for LENZ Therapeutics, Inc. (LENZ) over the past 18 months (most recent 2026-03-30). Recent activity: Chevallard Daniel R. (Chief Financial Officer) Buy 7,500 shares, George Jeffrey P. (Director) Buy 5,592 shares, Schimmelpennink Evert B. (President, CEO and Secretary) Buy 28,089 shares, Olsson Shawn (Chief Commercial Officer) Buy 10,000 shares, Olsson Shawn (Chief Commercial Officer) Sell 4,212 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Chevallard Daniel R. | Chief Financial Officer | Buy | 7,500 | $64,275 |
| 2026-03-30 | George Jeffrey P. | Director | Buy | 5,592 | $49,881 |
| 2026-03-30 | Schimmelpennink Evert B. | President, CEO and Secretary | Buy | 28,089 | $251,397 |
| 2025-11-19 | Olsson Shawn | Chief Commercial Officer | Buy | 10,000 | $20,800 |
| 2025-11-19 | Olsson Shawn | Chief Commercial Officer | Sell | 4,212 | $108,417 |
| 2025-11-19 | Olsson Shawn | Chief Commercial Officer | Sell | 5,788 | $152,630 |
| 2025-11-10 | MCCOLLUM JAMES W | Director | Buy | 10,500 | $239,295 |
| 2025-11-07 | Chevallard Daniel R. | Chief Financial Officer | Buy | 20 | $454 |
| 2025-11-07 | Chevallard Daniel R. | Chief Financial Officer | Buy | 2,178 | $49,571 |
| 2025-10-02 | Versant Vantage II GP, L.P. | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Venture Capital VI, L.P. | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Ventures VII GP, L.P. | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Ventures VI GP, L.P. | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Venture Capital VII, L.P. | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Ventures VII GP-GP, LLC | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Venture Capital VI, L.P. | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Ventures VI GP-GP, LLC | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Vantage II, L.P. | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | Versant Ventures VII GP, L.P. | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Vantage II GP, L.P. | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Venture Capital VII, L.P. | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Ventures VII GP-GP, LLC | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Vantage II GP-GP, LLC | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Ventures VI GP-GP, LLC | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | Versant Vantage II GP-GP, LLC | Insider | Sell | 49,701 | $2.3M |
Source: SEC Form 4 filings · as of 2026-03-30